White H Thorax.pdf (476.07 kB)
Latent tuberculosis infection screening and treatment in HIV: Insights from evaluation of UK practice
journal contribution
posted on 2017-01-18, 10:01 authored by Helena A. White, R. F. Miller, A. L. Pozniak, M. C. I. Lipman, Iain Stephenson, Martin J. Wiselka, Manish PareekLatent TB infection (LTBI) screening and treatment in HIV-positive individuals in the UK is advocated by the British HIV Association (BHIVA) and National Institute for Health and Care Excellence (NICE), although each recommends differing strategies. We undertook an evaluation of UK practice, relating the responses to the local HIV/TB disease burden. 162 of 188 (86%) UK geographical areas responded; only 93/162 (57.4%) offer LTBI testing with considerable heterogeneity in practice, and no difference in HIV/TB burden between areas offering testing and those who do not. Only 33/93 (35.5%) and 6/93 (6.5%) reported full compliance with BHIVA and NICE guidance respectively. A uniform national guideline is required.
History
Citation
Thorax 2017 Feb;72(2):180-182.Author affiliation
/Organisation/COLLEGE OF MEDICINE, BIOLOGICAL SCIENCES AND PSYCHOLOGY/School of Medicine/Department of Infection, Immunity and InflammationVersion
- AM (Accepted Manuscript)
Published in
Thorax 2017 Feb;72(2):180-182.Publisher
BMJ Publishing Group, British Thoracic Society (BTS)issn
0040-6376eissn
1468-3296Acceptance date
2016-09-21Available date
2017-01-18Publisher DOI
Publisher version
http://thorax.bmj.com/content/early/2016/10/14/thoraxjnl-2016-209063.abstractLanguage
enAdministrator link
Usage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC